Symrise S.R.L. Buys 20 Percent in U.S. Biotech Company, Therapeutic Peptides Inc.

HOLZMINDEN, Germany (Thomson Financial) - German scents and flavours maker Symrise AG. said it acquired a 20 percent stake in Therapeutic Peptides Inc., winning distribution rights to the U.S. biotechnology company's ingredients for cosmetics.